Neble George R sold $33K of EVER

Neble George R sold 1,593 shares of EverQuote, Inc. (EVER) at $20.83 on 2026-10-09 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Neble George R
Published Oct 13, 2026, 9:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$EVER
Bearish
medium confidence
Mentioned
$EVER
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$EVERBearishLow
01

Why it matters

The disclosed sale is small and pre‑arranged, likely causing only marginal price movement.

02

Market read

A routine insider sale with limited material impact; may be noted by short‑term traders but unlikely to drive significant price moves.

03

What to watch

Director may be diversifying holdings; the transaction was pre‑arranged under a 10b5‑1 plan.

Relevance 2/10Novelty 2/10Timing: filed today

Background

SEC Form 4 filings disclose insider transactions; investors monitor them for potential signals.

Company-level read

Ticker impact

$EVERBearishMedium confidence
Context

Director Neble George R sold 1,593 EverQuote shares for $33,182 on Oct 9 via a 10b5‑1 plan.

Expected impact

likely slight downward pressure as market prices in the insider sale

Evidence & confidence

The sale is modest in size ($33k) and represents a director reducing stake, which can be interpreted as a mild bearish signal.

Market effects

Minimal impact on the insurance/technology sector.

No regional effect.

Insignificant on a global scale.

Counterpoint

The sale could be routine portfolio rebalancing, not a negative signal.

Key entities

  • EverQuote, Inc.

    US‑listed insurer technology platform (ticker EVER).

  • Neble George R

    Director of EverQuote who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.